EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Toward Proteomic-Based Prediction of Ex Vivo Platinum Sensitivity in Ovarian Cancer Ascitic Cellular Aggregates: A Pilot Study

Jack Scanlan iD, Parul Mittal, Noor A Lokman, Martin K Oehler, Peter Hoffmann iD, Manuela Klingler-Hoffmann iD

Journal of Proteome Research · 2026

DOI: 10.1021/acs.jproteome.5c00771 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, 2026. Verfasst von Jack Scanlan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Mass Spectrometry and Proteomics Group, UniSA Clinical & Health Sciences, University of South Australia, Adelaide, SA 5000, Australia. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Proteomics, Spheroids, Cellular, Ascites. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Government of South Australia, University of South Australia, Bioplatforms Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsProteomicsSpheroids, CellularAscitesProteomeAntineoplastic AgentsHumansFemalePilot ProjectsCarboplatinDrug Resistance, NeoplasmAscitic FluidMiddle AgedAged

Stichwörter der Autor:innen

malignant ascitesmass spectrometryovarian cancerpersonalized medicineproteomicsspheroids

Substanzen

ProteomeCarboplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Mass Spectrometry and Proteomics Group, UniSA Clinical & Health Sciences, University of South Australia, Adelaide, SA 5000, Australia.
  • College of Health, Adelaide University, Adelaide, SA 5000, Australia.
  • Discipline of Obstetrics and Gynaecology, Adelaide Medical School, Robinson Research Institute, The University of Adelaide, Adelaide, SA 5005, Australia.
  • Department of Gynaecological Oncology, Royal Adelaide Hospital, Adelaide, SA 5000, Australia.

ORCID-Profile: Jack Scanlan, Peter Hoffmann, Manuela Klingler-Hoffmann

Förderung

  • Government of South Australia
  • University of South Australia
  • Bioplatforms Australia
  • Australian Government
  • Tour de Cure
  • Letitia Linke Research Foundation

Zitieren

APA

Scanlan, J., Mittal, P., Lokman, N. A., Oehler, M. K., Hoffmann, P., & Klingler-Hoffmann, M. (2026). Toward Proteomic-Based Prediction of Ex Vivo Platinum Sensitivity in Ovarian Cancer Ascitic Cellular Aggregates: A Pilot Study. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.5c00771

Vancouver

Scanlan J, Mittal P, Lokman NA, Oehler MK, Hoffmann P, Klingler-Hoffmann M. Toward Proteomic-Based Prediction of Ex Vivo Platinum Sensitivity in Ovarian Cancer Ascitic Cellular Aggregates: A Pilot Study. Journal of Proteome Research. 2026. doi:10.1021/acs.jproteome.5c00771

BibTeX
@article{Scanlan2026,
  author = {Scanlan, Jack and Mittal, Parul and Lokman, Noor A and Oehler, Martin K and Hoffmann, Peter and Klingler-Hoffmann, Manuela},
  title = {Toward Proteomic-Based Prediction of Ex Vivo Platinum Sensitivity in Ovarian Cancer Ascitic Cellular Aggregates: A Pilot Study},
  journal = {Journal of Proteome Research},
  year = {2026},
  doi = {10.1021/acs.jproteome.5c00771}
}
Kostenlos starten →